Aatmaj Healthcare Ltd Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- Target revenue for current year (FY 23-24): Around Rs. 28 to 32 crore, depending on PMJAY strategy.
- Projected revenue in 2-3 years (FY 25-26): Around Rs. 80 to 90 crore.
- Expected revenue for next year: Approximately Rs. 45 to 50 crore.
- Growth driven by strategic acquisitions of multi-specialty hospitals and expansion into new verticals like IVF centers.
- Expansion plan includes increasing bed capacity from current 330 beds to 430 beds.
- Geographic expansion planned in four states: Gujarat, Madhya Pradesh, Rajasthan, and Maharashtra by 2027.
- Focus on high-margin services such as IVF centers starting before the end of the current financial year.
- Emphasis on maintaining 20% net profit margin as turnover increases, though margins may vary with scale.
See what Aatmaj Healthcare Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
YesSee what Aatmaj Healthcare Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Recent CapEx was incurred to increase bed capacity from 130 to 330 beds, primarily through strategic acquisitions and leases rather than owning properties, minimizing capital outlay.
- No plans to invest in building ownership going forward; existing newly acquired hospitals are on rental/lease agreements.
- Planned CapEx of around ₹4-5 Cr over the next year for setting up 2 IVF centers, including equipment and operational costs.
- IVF centers expected to start before March 2024; potential for partnership or takeover of existing centers.
- Expansion plan includes increasing capacity to 430 beds and growing presence in Gujarat, Rajasthan, Madhya Pradesh, and Maharashtra.
- High-capital projects like oncology radiation therapy (costing ~₹16 Cr) are currently on hold due to financial prudence.
- No immediate plans for further fund raising for capital investments; focus is on organic growth and acquisitions.
Track Aatmaj Healthcare Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- Projected turnover for current year: around Rs. 30 crore
- Expected turnover in 2-3 years: Rs. 80 to 90 crore
- Anticipated turnover next year (approximate): Rs. 45 to 50 crore
- Net profit margin expected to be around 20% as turnover scales up
- EBITDA margin currently strong at 46.7% with PAT margin at 25.9% in H1 FY '24
- Future growth driven by strategic acquisitions, bed capacity expansion (from 330 to 430 beds), and new verticals like IVF centers
- IVF centers anticipated to start before March 2024, expected to generate high revenue and profit
- Operating margin expected to be maintained in future due to focused business model and cost control
- Expansion planned in four states (Gujarat, Madhya Pradesh, Rajasthan, Maharashtra) over next 2-3 years
- No immediate plans for further fund raising; focus on efficient management and organic growth
Order book
- The transcript does not explicitly mention the current or expected order book or pending orders.
- The focus is primarily on hospital acquisitions, expansions, and revenue projections rather than specific order books.
- The company has recently expanded bed capacity from 130 to 330 beds, aiming for 430 beds.
- Future growth strategies include expanding in states like Rajasthan, Madhya Pradesh, Gujarat, Maharashtra, and launching IVF centers.
- Revenue projections for the next 2-3 years are around Rs. 80-90 crores, with a 20% net profit margin aimed.
- No direct reference to an order book or pending orders is provided in the available transcript content.
How does Aatmaj Healthcare Ltd rank vs peers in Healthcare Services?
Pro featureHow does Aatmaj Healthcare Ltd rank in Healthcare Services?
Compare Aatmaj Healthcare Ltd against every Healthcare Services company (Q2 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Aatmaj Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Metropolis Healt (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
- Apollo Hospitals (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
- Health X Platform Ltd (Q1 FY27)
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
- Shalby Ltd (Q1 FY27)
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…